Trial Profile
Safety and efficacy of cetuximab plus irinotecan based therapy in patients with metastatic colorectal cancer : A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Oct 2016
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 17 Oct 2016 New trial record